Deborah Zajchowski

Deborah Zajchowski

Company: The Clearity Foundation

Job title: Scientific Director


Deborah Zajchowski, PhD is the Scientific Director of the Clearity Foundation, a non-profit foundation that aims to improve the survival and quality of life of women with ovarian cancer. Dr. Zajchowski joined Clearity at its inception in 2008 and oversees the patient services operations and the Foundation’s research efforts. Under her leadership, the Foundation has developed an online interactive tumor profiling report, ovarian cancer-specific clinical trial search tool, and treatment option guide that provides information about standard and novel treatments for ovarian cancer —tailored to the patient’s specific tumor molecular characteristics and clinical situation.

As a cancer biologist, she has been involved in cancer research and drug/target discovery and development for more than 25 years. Prior to joining Clearity, Dr. Zajchowski had positions of increasing responsibility at Berlex Biosciences, a subsidiary of Schering AG (now Bayer Pharmaceuticals), where she led multi-disciplinary research efforts in oncology and cardiovascular disease. She is a member of the American Association for Cancer Research and the American Society of Clinical Oncology and has published many research articles on cancer genomics, estrogen action, and transcriptional control. Dr. Zajchowski received her Ph.D. in Biochemistry from the University of Chicago.

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.